Nilotinib Capsules Exporter from India | Genliva Wellness LLP Oncology Pharma Manufacturer

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Nilotinib Capsules are targeted anticancer medications used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). The medicine works by inhibiting the BCR-ABL tyrosine kinase enzyme responsible for the uncontrolled growth of leukemia cells. Genliva Wellness LLP is a trusted Nilotinib Capsules Manufacturer in India offering high-quality oncology formulations for domestic and international pharmaceutical markets.

This oral formulation is widely prescribed for patients with newly diagnosed or resistant chronic myeloid leukemia. As a reliable Nilotinib Capsules Exporter from India, Genliva Wellness LLP supplies quality-assured oncology products to healthcare institutions and pharmaceutical distributors worldwide.

Nilotinib is a second-generation tyrosine kinase inhibitor that provides targeted treatment for leukemia and helps achieve effective disease control by selectively acting on abnormal cancer cells.

Nilotinib Capsules are formulated to provide targeted therapy for chronic myeloid leukemia.

Contains Nilotinib as the active ingredient
Tyrosine kinase inhibitor (TKI)
Targets BCR-ABL protein activity
Helps inhibit leukemia cell proliferation
Selective action against abnormal cells
Oral capsule formulation

Nilotinib Capsules are used in the treatment and management of chronic myeloid leukemia.

Philadelphia chromosome-positive chronic myeloid leukemia
Newly diagnosed chronic myeloid leukemia
Chronic phase CML
Accelerated phase CML
Resistant or intolerant CML cases
Long-term leukemia management

Nilotinib Capsules provide targeted anticancer activity for effective leukemia treatment.

Helps suppress leukemia cell growth
Targets the underlying cause of CML
Supports long-term disease control
Effective in resistant leukemia cases
Reduces progression of the disease
Contributes to improved therapeutic response